These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37461802)

  • 1. Life span-associated ferroptosis-related genes identification and validation for hepatocellular carcinoma patients as hepatitis B virus carriers.
    Weng W; Zhang D; Li S
    J Clin Lab Anal; 2023 Jul; 37(13-14):e24930. PubMed ID: 37461802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
    Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
    Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma.
    Zhang Y; Ren H; Zhang C; Li H; Guo Q; Xu H; Cui L
    Front Immunol; 2022; 13():1028054. PubMed ID: 36304446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis-related local immune cytolytic activity in tumor microenvironment of basal cell and squamous cell carcinoma.
    Wang J; Xie D; Wu H; Li Y; Wan C
    Aging (Albany NY); 2022 May; 14(9):3956-3972. PubMed ID: 35501667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prognostic risk model, tumor immune environment modulation, and drug prediction of ferroptosis and amino acid metabolism-related genes in hepatocellular carcinoma.
    Ji L; Zhang Q; Cao Y; Liu L
    Hum Cell; 2023 May; 36(3):1173-1189. PubMed ID: 36892792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identify an innovative ferroptosis-related gene in hepatocellular carcinoma.
    Hu G; Huang X; Zhang B; Gao P; Wu W; Wang J
    J Clin Lab Anal; 2022 Sep; 36(9):e24632. PubMed ID: 35908779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-Related Gene SLC1A5 Is a Novel Prognostic Biomarker and Correlates with Immune Microenvironment in HBV-Related HCC.
    Su H; Liu Y; Huang J
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity.
    Zhao JW; Zhao WY; Cui XH; Xing L; Shi JC; Yu L
    Clin Transl Oncol; 2024 Feb; 26(2):496-514. PubMed ID: 37407805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases.
    Ma Q; Hui Y; Huang BR; Yang BF; Li JX; Fan TT; Gao XC; Ma DY; Chen WF; Pei ZX
    Transl Cancer Res; 2023 Jan; 12(1):46-64. PubMed ID: 36760376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia.
    Pan B; Li Y; Xu Z; Miao Y; Yin H; Kong Y; Zhang X; Liang J; Xia Y; Wang L; Li J; Wu J; Xu W
    Front Immunol; 2022; 13():962000. PubMed ID: 36275721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
    Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
    Aging (Albany NY); 2021 Nov; 13(22):24866-24881. PubMed ID: 34839280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
    Wang F; Chen C; Chen WP; Li ZL; Cheng H
    Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
    Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
    Front Immunol; 2022; 13():929089. PubMed ID: 35874689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma.
    Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H
    Cancer Med; 2024 Jan; 13(1):e6848. PubMed ID: 38151984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B.
    Yan P; Luo Y; Huang Z; Mou T; Yang H; Peng D; Wu Z
    BMC Gastroenterol; 2023 Nov; 23(1):390. PubMed ID: 37957550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma.
    Wang Q; Wang B; Ma X; Zhuang H; Xie Z; Tang C; Tan W; Yang L; Shang C; Chen Y
    J Hepatocell Carcinoma; 2023; 10():1-16. PubMed ID: 36647389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma.
    Zhang B; Zhao J; Liu B; Shang Y; Chen F; Zhang S; He J; Fan Y; Tan K
    Front Mol Biosci; 2022; 9():940575. PubMed ID: 35847985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.